EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis

Jingfeng Qian, Yanqiu Xu

Clinical Nephrology · 01.02.2026 · 105 (2) · 128-149

DOI: 10.5414/cn111749 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Nephrology, erschienen am 01.02.2026. Verfasst von Jingfeng Qian und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Renal Insufficiency, Chronic, Kidney, Diabetic Nephropathies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsRenal Insufficiency, ChronicKidneyDiabetic NephropathiesDiabetes Mellitus, Type 2Hypoglycemic AgentsHumansGlomerular Filtration RateRandomized Controlled Trials as TopicTreatment OutcomeDisease ProgressionDose-Response Relationship, DrugAcute Kidney Injury

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Zitieren

APA

Qian, J., & Xu, Y. (2026). Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis. Clinical Nephrology, 105(2), 128-149. https://doi.org/10.5414/cn111749

Vancouver

Qian J, Xu Y. Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis. Clinical Nephrology. 2026;105(2):128-149. doi:10.5414/cn111749

BibTeX
@article{Qian2026,
  author = {Qian, Jingfeng and Xu, Yanqiu},
  title = {Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis},
  journal = {Clinical Nephrology},
  year = {2026},
  volume = {105},
  number = {2},
  pages = {128--149},
  doi = {10.5414/cn111749}
}
Kostenlos starten →